Pacira Pharmaceuticals recalls

Pacira Pharmaceuticals appears in 4 official U.S. recall notices indexed by RecallRadar, most recently on 2024-07-03.

Company names are normalized from agency data (legal suffixes removed), so related firms may appear under separate pages.

• Zilretta (triamcinolone acetonide extended-release injectable suspension), 32 mg per vial, Rx only, Manufactured for: Pacira Pharmaceutical…
  FDA Drug · Class II · 2024-07-03 · Pacira Pharmaceuticals
• Drug Vial Label: Zilretta¿ (triamcinolone acetonide extended-release injectable suspension), 32 mg per vial, Rx only, Manufactured for: Pac…
  FDA Drug · Class II · 2024-06-19 · Pacira Pharmaceuticals
• EXPAREL, Bupivicaine Liposome Injectable Suspension, 1.3%, 266 mg/20 mL (13 mg/mL), Sterile, 20 mL vial, Rx only, Manufactured by: Pacira P…
  FDA Drug · Class II · 2019-12-11 · Pacira Pharmaceuticals
• EXPAREL (bupivacaine liposome injectable suspension), 1.3%, 266 mg/20 mL (13.3 mg/mL) single use vials, INVESTIGATIONAL USE. For Infiltrati…
  FDA Drug · Class II · 2013-03-06 · Pacira Pharmaceuticals